News

Kerassentials is a meticulously formulated toenail infection treatment solution that targets more problematic issues, such as ...
ImmunoPrecise Antibodies Ltd. (IPA) a leader in AI-driven biotherapeutics, announces discovery of a highly conserved epitope across all four dengue virus serotypes using its proprietary LENSaitm ...
GRCE READ THE FULL GRCE RESEARCH REPORT Grace Therapeutics, Inc (NASDAQ:GRCE) will soon submit its new drug application (NDA) ...
A pop-up overdose prevention tent is now running once a week in downtown St. John's. Overdose Awareness and Response St.
The U.S. Patent and Trademark Office (USPTO) held a “USPTO Hour” Wednesday in which it announced the results of a study it ...
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...
The government’s Strong Borders Act would let Canada Post and police open mail, create powers to cancel immigration en masse and more ...
Mohamed Soliman, who was born in Egypt and lived in Kuwait for 17 years, arrived in the U.S. in August 2022 on a tourist visa ...
As a result of the decision, Shilpa will not be eligible to receive FDA approval for its lenvatinib mesylate generic until February 2036.
Five early-career Fred Hutch/UW researchers received prestigious Young Investigator Awards from Conquer Cancer, the ASCO Foundation during this year's annual meeting of the American Society of ...
Genetic screening technology now allows parents employing in vitro fertilization (IVF) to select for certain traits, allowing ...
As previously announced, the FDA also granted iopofosine I 131 Fast Track Designation and Orphan Drug Designation. The ...